These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 29673970

  • 1. The role of compartmentalized signaling pathways in the control of mitochondrial activities in cancer cells.
    Rinaldi L, Delle Donne R, Borzacchiello D, Insabato L, Feliciello A.
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):293-302. PubMed ID: 29673970
    [Abstract] [Full Text] [Related]

  • 2. Control of mitochondria dynamics and oxidative metabolism by cAMP, AKAPs and the proteasome.
    Carlucci A, Lignitto L, Feliciello A.
    Trends Cell Biol; 2008 Dec; 18(12):604-13. PubMed ID: 18951795
    [Abstract] [Full Text] [Related]

  • 3. Mitochondria and cancer chemoresistance.
    Guerra F, Arbini AA, Moro L.
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [Abstract] [Full Text] [Related]

  • 4. Mitochondrial Biogenesis and Mitochondrial Reactive Oxygen Species (ROS): A Complex Relationship Regulated by the cAMP/PKA Signaling Pathway.
    Bouchez C, Devin A.
    Cells; 2019 Mar 27; 8(4):. PubMed ID: 30934711
    [Abstract] [Full Text] [Related]

  • 5. Mitochondrial cAMP-PKA signaling: What do we really know?
    Ould Amer Y, Hebert-Chatelain E.
    Biochim Biophys Acta Bioenerg; 2018 Sep 27; 1859(9):868-877. PubMed ID: 29694829
    [Abstract] [Full Text] [Related]

  • 6. Mitochondrial cAMP signaling.
    Zhang F, Zhang L, Qi Y, Xu H.
    Cell Mol Life Sci; 2016 Dec 27; 73(24):4577-4590. PubMed ID: 27233501
    [Abstract] [Full Text] [Related]

  • 7. Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration.
    Palorini R, De Rasmo D, Gaviraghi M, Sala Danna L, Signorile A, Cirulli C, Chiaradonna F, Alberghina L, Papa S.
    Oncogene; 2013 Jan 17; 32(3):352-62. PubMed ID: 22410778
    [Abstract] [Full Text] [Related]

  • 8. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V, Ben-Hail D, Admoni L, Krelin Y, Tripathi SS.
    Biochim Biophys Acta; 2015 Oct 17; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [Abstract] [Full Text] [Related]

  • 9. Control of mitochondrial biogenesis and function by the ubiquitin-proteasome system.
    Bragoszewski P, Turek M, Chacinska A.
    Open Biol; 2017 Apr 17; 7(4):. PubMed ID: 28446709
    [Abstract] [Full Text] [Related]

  • 10. Friend or foe? Mitochondria as a pharmacological target in cancer treatment.
    Dickerson T, Jauregui CE, Teng Y.
    Future Med Chem; 2017 Dec 17; 9(18):2197-2210. PubMed ID: 29182013
    [Abstract] [Full Text] [Related]

  • 11. Mitochondria and Cancer.
    Zong WX, Rabinowitz JD, White E.
    Mol Cell; 2016 Mar 03; 61(5):667-676. PubMed ID: 26942671
    [Abstract] [Full Text] [Related]

  • 12. Shaping mitochondrial dynamics: The role of cAMP signalling.
    Di Benedetto G, Gerbino A, Lefkimmiatis K.
    Biochem Biophys Res Commun; 2018 May 27; 500(1):65-74. PubMed ID: 28501614
    [Abstract] [Full Text] [Related]

  • 13. Protective mechanisms involving enhanced mitochondrial functions and mitophagy against T-2 toxin-induced toxicities in GH3 cells.
    Deyu H, Luqing C, Xianglian L, Pu G, Qirong L, Xu W, Zonghui Y.
    Toxicol Lett; 2018 Oct 01; 295():41-53. PubMed ID: 29870751
    [Abstract] [Full Text] [Related]

  • 14. Current and upcoming mitochondrial targets for cancer therapy.
    Kim HK, Noh YH, Nilius B, Ko KS, Rhee BD, Kim N, Han J.
    Semin Cancer Biol; 2017 Dec 01; 47():154-167. PubMed ID: 28627410
    [Abstract] [Full Text] [Related]

  • 15. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
    Ralph SJ, Rodríguez-Enríquez S, Neuzil J, Saavedra E, Moreno-Sánchez R.
    Mol Aspects Med; 2010 Apr 01; 31(2):145-70. PubMed ID: 20206201
    [Abstract] [Full Text] [Related]

  • 16. A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds.
    Kalyanaraman B, Cheng G, Hardy M, Ouari O, Lopez M, Joseph J, Zielonka J, Dwinell MB.
    Redox Biol; 2018 Apr 01; 14():316-327. PubMed ID: 29017115
    [Abstract] [Full Text] [Related]

  • 17. Mitofusins, from Mitochondria to Metabolism.
    Schrepfer E, Scorrano L.
    Mol Cell; 2016 Mar 03; 61(5):683-694. PubMed ID: 26942673
    [Abstract] [Full Text] [Related]

  • 18. Mitochondrial Changes in Cancer.
    Gururaja Rao S.
    Handb Exp Pharmacol; 2017 Mar 03; 240():211-227. PubMed ID: 27718058
    [Abstract] [Full Text] [Related]

  • 19. Targeting mitochondria metabolism for cancer therapy.
    Weinberg SE, Chandel NS.
    Nat Chem Biol; 2015 Jan 03; 11(1):9-15. PubMed ID: 25517383
    [Abstract] [Full Text] [Related]

  • 20. A dynamic interface between ubiquitylation and cAMP signaling.
    Rinaldi L, Sepe M, Donne RD, Feliciello A.
    Front Pharmacol; 2015 Jan 03; 6():177. PubMed ID: 26388770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.